Greenlight Capital Re (NASDAQ:GLRE – Get Free Report) posted its earnings results on Monday. The financial services provider reported ($0.81) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.59 by ($1.40), Zacks reports. Greenlight Capital Re had a return on equity of 13.95% and a net margin of 12.38%.
Greenlight Capital Re Stock Down 1.8 %
Shares of GLRE traded down $0.25 on Monday, hitting $13.70. The company’s stock had a trading volume of 58,981 shares, compared to its average volume of 81,190. The firm’s fifty day moving average price is $13.71 and its 200-day moving average price is $13.96. The firm has a market capitalization of $477.20 million, a price-to-earnings ratio of 5.44 and a beta of 0.86. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 0.09. Greenlight Capital Re has a fifty-two week low of $11.72 and a fifty-two week high of $15.82.
Wall Street Analyst Weigh In
Separately, StockNews.com raised shares of Greenlight Capital Re from a “hold” rating to a “buy” rating in a research note on Friday, January 31st.
Greenlight Capital Re Company Profile
Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurance company worldwide. The company offers various property reinsurance products and services, including automobile physical damage, personal lines, and commercial lines. It also provides casualty reinsurance products and services comprising general liability, motor liability, professional liability, and worker's compensation; and accident and health, transactional liability, mortgage insurance, surety, trade credit, marine, and energy, as well as other specialty products, such as aviation, crop, cyber, political, and terrorism products.
Further Reading
- Five stocks we like better than Greenlight Capital Re
- 5 discounted opportunities for dividend growth investors
- How to Protect Your Portfolio When Inflation Is Rising
- How to Invest in Insurance Companies: A GuideĀ
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Invest in the Best Canadian StocksĀ
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Greenlight Capital Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenlight Capital Re and related companies with MarketBeat.com's FREE daily email newsletter.